Editorial Board
Editors-in-Chief
José Leopoldo Ferreira Antunes
Marco Aurelio De Anselmo Peres
Editorial Board
Abla Mehio Sibai
Líbano
Akindele Olupelumi Adebiyi
Nigeria
Aluísio J. D. Barros
Brazil
Currently a Professor of Epidemiology at Universidade Federal de Pelotas (UFPel), he co-founded and directs the International Center for Equity in Health (ICEH) and leads research for the Pelotas birth cohorts. Since 2009, his work has focused on tracking health inequalities in low- and middle-income countries alongside initiatives like Countdown to 2030, WHO, and UNICEF. His key contributions include perfecting equiplots and developing global health indicators such as SWPER (women’s empowerment) and ANCq (antenatal care quality). He also teaches advanced statistics and mentors postgraduate scholars internationally.
An Pan
China
Ana Isabel Ribeiro
Portugal
Ashley Felix
USA
Benjamin W. Chaffee
USA
Bernardo Horta
Brazil
Jonathan Huang
Brigid M. Lynch
Australia
Brigid M. Lynch PhD is Senior Principal Research Fellow at Cancer Council Victoria and Honorary Professorial Fellow at the University of Melbourne. Her research focuses on cancer epidemiology, modifiable risk factors, molecular and genetic epidemiology, and causal inference. She is a principal investigator of the Australian Breakthrough Cancer Study, a cohort of more than 50,000 adults investigating how genetic, environmental, and behavioural factors influence cancer risk. She currently serves as the Western Pacific Regional Councillor of the International Epidemiological Association and is a Past President and Fellow of the Australasian Epidemiological Association.
Britton Trabert
USA
C Mary Schooling
China
Carme Borrell
Spain
Camille Raynes-Greenow
Christina Song Ci
China
David M. Evans
Australia
David Henry
Australia
David Henry is Honorary/ Adjunct Professor at Bond University, the University of New South Wales and the University of Melbourne, in Australia. He also holds the positions of Professor Emeritus at the Faculty of Medicine, University of Toronto and Emeritus Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Ontario, Canada.
He graduated in medicine at the University of Glasgow, UK and is a Fellow of the Royal College of Physicians of Edinburgh. He specialised in general internal medicine, clinical pharmacology and gastroenterology at the University of Nottingham UK, before moving to Australia as a general physician and professor of clinical pharmacology at the University of Newcastle, NSW. In that role he was involved extensively in the evaluation of medicines for public subsidy in Australia and in the development of the discipline of pharmacoepidemiology.
Subsequently, in Canada he held the position of President and CEO at the Institute for Clinical Evaluative Sciences (ICES) in Toronto and Professor of Health Systems Data at the University of Toronto, Canada.
He has retired from clinical practice and lives on the sub-tropical northeastern coast of New South Wales, where he is a volunteer firefighter.
Haidong Kan
China
Ali Khashan
Jennifer Nuzzo
USA
Jixuan Ma
China
Johannes Textor
The Netherlands
José Manuel Aburto
UK
Jun Lv
China
Katy Bell
Australia
Kosuke Inoue
Japan
Kosuke Inoue, MD, PhD, is a Professor in the Department of Health Promotion and Behavioral Sciences at Kyoto University, Graduate School of Medicine. He is a physician-epidemiologist with clinical training in endocrinology and advanced methodological training in epidemiology, particularly causal inference and machine learning. He received his MD from the University of Tokyo in 2013 and his PhD in Epidemiology from the UCLA Fielding School of Public Health in 2021.
His research focuses on cardiometabolic and endocrine epidemiology, using randomized trials, large-scale real-world data, and digital health data to evaluate prevention and treatment strategies for chronic diseases. His work integrates modern causal inference and machine learning methods, including target trial emulation, causal mediation analysis, and estimation of heterogeneous treatment effects, to establish causal mechanisms linking the treatment/exposure to the outcome and to identify individuals most likely to benefit from clinical and public health interventions.
He has published widely in leading medical and epidemiology journals, including BMJ, JAMA, and the International Journal of Epidemiology, and is actively involved in scientific publishing, peer review, and editorial activities. He was selected as one of the MIT Technology Review Innovators Under 35 in Japan in 2023 and received the Society for Epidemiologic Research’s Brian MacMahon Early Career Epidemiologist Award in 2026.
Kristian Filion
Canada
Laith Jamal Abu Raddad
Qatar
Laura Rosella
Canada
Lin Shelly Xu
China
Michael Cook
UK
Michael Harhay
USA
Michelle Kelly-Irving
France
Mika Ala-Korpela
Finland
Mohammad A. Mansournia
Iran
Mohammad Talaei
UK
Murthy Mittinty
Australia
Nancy H. L. Leung
China
Nicholas Osborne
Australia
Nicole Warrington
Australia
Onyebuchi Arah
USA
Pedro Curi Hallal
USA
Saman Khalatbari Soltani
Australia
Sheena Sullivan
Australia
Stephen Burgess
UK
Tania King
Australia
Tania King is an Associate Professor and Deputy Director of the Social Equity Research Centre at RMIT University. She completed her PhD in Social Epidemiology at the University of Melbourne.
Her research is broadly focused on social and structural determinants of mental health and suicide inequalities. A central focus is understanding the mechanisms through which gender shapes mental health, particularly in relation to paid and unpaid work as gendered exposures. Her research examines how the gendered distribution of employment, caring responsibilities and workplace conditions produces inequalities in mental health across the life-course.
A quantitative social epidemiologist, her work commonly draws on the large cohort studies and linked administrative data to examine the impact of different social determinants on mental health and suicide risk, and to identify optimal points of intervention.
Tania Maria de Araujo
Brazil
Tazeen Hasan Jafar
Singapura
Professor Tazeen H. Jafar, MD MPH FASN is globally renowned for her extensive expertise and experience in clinical trials, health systems research, and implementation science. Her work focuses on addressing major health challenges such as hypertension, cardiovascular disease, and chronic kidney disease. She is particularly known for her contributions to risk prediction and the development of community-based interventions to improve health outcomes.
Dr. Jafar is a Professor in the Program in Health Services and Population Health Research at Duke-NUS Medical School, Singapore, and holds multiple key roles: Visiting Consultant in Renal Medicine at Singapore General Hospital, Consultant Nephrologist at Durham VA Healthcare System, and Professor at Duke Global Health Institute, Duke University, Durham, NC, USA.
Professor Jafar went to medical school at the Aga Khan University, Karachi, Pakistan, followed by residency in Medicine-Pediatrics (and dual board certification) from University of Texas Health Science Center at Houston, and fellowship in clinical nephrology (with board certification in Nephrology) and clinical research at Tufts Medical Center, Boston. She also obtained master’s in public health from Harvard University.
Professor Jafar has led impactful global health research on chronic non-communicable diseases for over 25 years, supported by grants from MRC, Wellcome Trust, NIH, and Singapore NMRC. She is the chief principal investigator of the COBRA-BPS trial, a landmark study across 30 rural South Asian villages demonstrating a scalable, community health worker–led approach to blood pressure control with potential to reach nearly one billion people in low- and middle-income countries. She has also led key work on GFR estimation and kidney disease risk prediction in South Asians and is a member of the global CKD Prognosis Consortium. She is also a practising nephrologist.
Tony Blakely
Australia
Tony leads the Scalable Health Intervention Evaluation program (SHINE), which is a data science and simulation platform leveraging burden of disease data and methods to rapidly estimate health, health inequality, cost and productivity impacts of virtually any preventive intervention, in any country.